Compliant dehydrated tissue for implantation and process of making the same

• US 6,277,555 B1
• Filed: 03/24/2000
• Issued: 08/21/2001
• Est. Priority Date: 06/24/1998
• Status: Expired due to Term

• Current Assignee: The International Heart Institute of Montana Foundation
• Original Assignee: The International Heart Institute of Montana Foundation
• Inventors: Cheung, David T., Pang, David C., Duran, Carlos M. G.
• Primary Examiner(s): Prats, Francisco
• Assistant Examiner(s): OZGA, BRETT T
• Application Number:
  US09/535,490
• Time in Patent Office: 515 Days
• Field of Search: 435/1.1, 435/1.3, 435/325, 435/326, 435/374, 435/378
• US Class Current: 435/1.3
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3687 characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
• CPC Class Codes: A61L 27/3691 characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
• CPC Class Codes: Y10S 623/915 Method or apparatus for preparing biological material
• CPC Class Codes: Y10S 623/917 Collagen

Abstract

A process for preparing pliable soft tissue specimen which are resistant to cracking and devoid of viable cells includes the steps of treating native soft tissue obtained from a donor by a gradually increasing gradient of aliphatic alcohol or other suitable water miscible polar organic solvent until the last alcohol (or other solvent) solution has at least 25% by volume of the organic liquid. Thereafter, the tissue specimen is treated with a solution containing glycerol or low molecular weight (<1000 D) polyethylene glycol, and polyethylene glycol of a molecular weight between approximately 6,000 to 15,000 D and heparin. Thereafter, the tissue specimen is briefly immersed in aqueous heparin solution, frozen and lyophilized. The tissue specimen is suitable for implantation as a homograft or xenograft, with or without rehydration.

Claims

1. A process for preparing a pliable soft tissue specimen, comprising the steps of:

(1) treating natural soft tissue obtained from a donor with;

(a) liquid compositions of gradually increasing concentrations of a polar organic solvent or solvents, until the last of said liquid compositions contains at least approximately 25% by volume of said solvent, or mixture of solvents, the balance being water, the solvent being selected from a group consisting of aliphatic alcohols having 1 to 3 carbons and other water miscible polar organic solvents;

(b) thereafter with a second liquid composition of aqueous glycerol or of low molecular weight polyethylene glycol having a molecular weight less than approximately 1000 D, the glycerol or the low molecular weight polyethylene glycol, or mixtures thereof being in a concentration range of approximately 10 to 50% by volume, said second liquid composition also containing approximately 3-20% weight by volume of polyethylene glycol of a molecular weight in the range of 6,000 D to 15,000 D and approximately 2 to 75 units per milliliter heparin of a molecular weight greater than approximately 3 KD;

(2) thereafter briefly immersing the soft tissue in an aqueous heparin solution, and

(3) thereafter freezing the tissue and lyophilizing the tissue to dryness.

2. The process in accordance with claim 1 wherein the polar organic solvents are selected from the group consisting of methyl alcohol, ethyl alcohol, iso-propyl alcohol, acetonitrile, acetone and methyl ethyl ketone.

3. The process in accordance with claim 2 wherein the polar organic solvent is ethyl alcohol.

4. The process in accordance with claim 1 wherein the natural soft tissue obtained from the donor is treated with liquid compositions of gradually increasing concentrations of a polar organic solvent or solvents, until the last of said liquid compositions contains at least approximately 50% by volume of said solvent, or mixture of solvents.

5. The process in accordance with claim 4 where the polar organic solvent is ethyl alcohol.

6. The process in accordance with claim 1 wherein the second liquid composition contains approximately 20% by volume of glycerol.

7. The process in accordance with claim 1 wherein the natural soft tissue is treated in succession with two liquid compositions of a polar organic solvent or solvents, the first of said compositions containing approximately 15 to 35% by volume of the solvent or solvents, the second of said composition containing approximately 25 to 75% by volume of the solvent or solvents.

8. The process in accordance with claim 7 wherein the polar organic solvent is ethyl alcohol.

9. The process in accordance with claim 1 further comprising the step of rehydrating the lyophilized tissue specimen.

10. A process for preparing a pliable soft mammalian tissue specimen, for eventual implantation in a mammal to replace or augment native tissue, the process comprising the steps of:

(1) treating natural soft mammalian tissue obtained from a donor with;

(a) liquid compositions of gradually increasing concentrations of an aliphatic alcohol or mixture of aliphatic alcohols having 1 to 3 carbon atoms, until the last of said liquid compositions contains at least approximately 25% by volume of said alcohol or mixture of alcohols, the balance being water;

(b) thereafter with a second liquid composition of aqueous glycerol containing the glycerol in a concentration range of approximately 10 to 50% by volume, said second liquid composition also containing approximately 3-20% weight by volume polyethylene glycol of a molecular weight in the range of 6,000 D to 15,000 D and approximately 2 to 75 units per milliliter heparin of a molecular weight greater than approximately 3 KD;

(2) thereafter briefly immersing the soft tissue in an aqueous heparin solution of approximately 20 to 500 units per milliliter concentration, and

(3) thereafter freezing the tissue and lyophilizing the tissue to dryness.

11. The process in accordance with claim 10 wherein the aliphatic alcohol is ethyl alcohol.

12. The process in accordance with claim 11 wherein the natural soft tissue is treated with said compositions containing ethyl alcohol, until the last of said compositions contains at least approximately 50% by volume ethyl alcohol.

13. The process in accordance with claim 12 wherein the concentration of glycerol in the second liquid composition is approximately 20% by volume.

14. The process in accordance with claim 13 wherein the concentration of polyethylene glycol in the second liquid composition is approximately 5% weight by volume and the molecular weight of said polyethylene glycol is approximately 8,000 D.

15. The process in accordance with claim 14 wherein the natural soft tissue is treated in succession with two liquid compositions of ethyl alcohol, the first of said compositions containing approximately 15 to 35% by volume of ethyl alcohol, the second of said composition containing approximately 25 to 75% by volume of ethyl alcohol.

16. The process in accordance with claim 15 further comprising the step of rehydrating the lyophilized tissue specimen.

17. The process in accordance with claim 10 wherein the natural soft mammalian tissue is selected from the group consisting of pericardium, pleura, peritoneum from aortic valve, pulmonary valve, mitral valve, tricuspid valve, tendon and skin.